Indivior

About:

Indivior is a specialty pharmaceuticals business.

Website: http://indivior.com/

Twitter/X: indivior

Top Investors: Oaktree Capital Management, Piper Sandler

Description:

The world leader in addiction treatment with 20 years of experience and a unique, patient-focused approach. They didn’t become the world leader in addiction treatment overnight. Their endeavor started small, with one singular focus – to intimately understand the journey of individuals suffering with addiction. People with addiction are often stereotyped and discounted, creating an environment where many are under-diagnosed, undertreated and under-supported. They’re often unaware of their treatment options, have limited access to treatment, or simply don’t seek it out because they’re afraid of being stigmatized.

Total Funding Amount:

$400M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Richmond, Virginia, United States

Founded Date:

2014-01-01

Contact Email:

Tom.Corran(AT)indivior.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2024-11-05

IPO Status:

Public

© 2025 bioDAO.ai